Trospium Chloride Tablet, Film Coated
Product Images NDC 0904-7059

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Trospium Chloride (NDC 0904-7059). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

0f16a8b8 Be7f 41e6 A5ca C97aba610d43 00

Trospium Chloride Tablets USP 20 mg film-coated tablets label from Major Pharmaceuticals. The label indicates a package containing 60 tablets for oral use. It includes storage instructions, dispensing guidance, and manufacturer details for Heritage Pharmaceuticals Inc., East Brunswick, NJ.*

FDA Label Image

0f16a8b8 Be7f 41e6 A5ca C97aba610d43 01

Chemical structure diagram of Trospium Chloride, showing the molecular arrangement including cyclopentylammonium and ester functional groups, along with chloride ion representation.*

FDA Label Image

0f16a8b8 Be7f 41e6 A5ca C97aba610d43 02

A line graph depicting plasma concentration (ng/mL) versus time (hours post-dose), showing plasma levels measured from 0 to 48 hours after dosing with Trospium Chloride. Error bars indicating variability appear at multiple time points during the study duration.*

FDA Label Image

0f16a8b8 Be7f 41e6 A5ca C97aba610d43 03

Line graph comparing mean change over 12 weeks of treatment between placebo and Trospium Chloride groups. The y-axis shows mean (± SE) change, and the x-axis shows weeks of treatment (1, 4, 12). Data points for each group include error bars and p-values for statistical significance.*

FDA Label Image

0f16a8b8 Be7f 41e6 A5ca C97aba610d43 04

A line graph comparing mean (± SE) change over 12 weeks of treatment between placebo and Trospium Chloride groups. The x-axis shows weeks of treatment (1, 4, 12), and the y-axis shows mean change values. Data points for placebo and Trospium Chloride are shown with corresponding p-values noted at weeks 1, 4, and 12.*

FDA Label Image

0f16a8b8 Be7f 41e6 A5ca C97aba610d43 05

A line graph comparing mean changes over weeks of treatment between Trospium Chloride and placebo groups. The y-axis represents mean change with standard error, while the x-axis shows weeks of treatment (1, 4, 12). Trospium Chloride shows greater mean reduction at all time points compared to placebo with statistically significant p-values indicated.*

FDA Label Image

0f16a8b8 Be7f 41e6 A5ca C97aba610d43 06

A line graph comparing mean changes over weeks of treatment between Trospium Chloride and placebo groups. The x-axis shows weeks of treatment (1, 4, 12), and the y-axis shows mean change with standard error. Trospium Chloride shows a larger decrease over time than placebo, with p-values less than 0.001 at all points.*

FDA Label Image

0f16a8b8 Be7f 41e6 A5ca C97aba610d43 07

FDA Label Image

0f16a8b8 Be7f 41e6 A5ca C97aba610d43 08

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.